Attached files

file filename
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC.exhibit311q32018.htm
EX-99.1 - CERTAIN LITIGATION MATTERS - ALTRIA GROUP, INC.exhibit991q32018.htm
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC.exhibit322q32018.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 - ALTRIA GROUP, INC.exhibit321q32018.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A) - ALTRIA GROUP, INC.exhibit312q32018.htm
EX-12 - STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES - ALTRIA GROUP, INC.exhibit12computationofrati.htm
10-Q - FORM 10-Q - ALTRIA GROUP, INC.a2018form10qq32018.htm

Exhibit 99.2



TRIAL SCHEDULE FOR CERTAIN CASES

Below is a schedule, as of October 22, 2018 setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for trial through December 31, 2018.

2018

Engle progeny                        
October
1
 
 
November
4
 
 
December
0

As of October 22, 2018, there are no Engle progeny cases in trial.

Other Individual Smoking & Health
October
1
 
 
November
0
 
 
December
1

As of October 22, 2018, there are no non-Engle progeny cases in trial.